Anaesthesiology and Intensive Care Medicine, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Medical Epidemiology, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Crit Care. 2024 Nov 14;28(1):368. doi: 10.1186/s13054-024-05147-z.
BACKGROUND: Understanding how preexisting comorbidities may interact with a critical illness is important for the assessment of long-term survival probability of older patients admitted to the ICU. MATERIAL AND METHODS: The mortality after a first ICU admission in patients ≥ 55 years old registered in the Swedish Intensive Care Registry was compared to age- and sex-matched individuals from the general population with a landmark after 1 year. The comparison was adjusted for age, sex, and baseline comorbidity using Cox regression. RESULTS: The 7-year study period included 140 008 patients, of whom 23% were 80 years or older. Patients surviving the first year remained at an increased risk compared to the general population, but much of this difference was attenuated after adjustment for baseline comorbidity (HR, 1.03; 95% CI 1.02-1.04). Excluding cardio-thoracic ICU admissions, the increased risk remained slightly elevated (adjusted HR, 1.15; 95% CI 1.13-1.16). Also, the subgroup ≥ 75 years old surviving the first year returned to a mortality rate comparable to the general population (HR, 0.98; 95% CI 0.96-0.99). Stratified by admission diagnosis an increased mortality rate remained beyond the first year for acute-on-chronic respiratory failure (adjusted HR, 1.47; 95% CI 1.36-1.58) but not for other respiratory causes (adjusted HR, 1.03; 95% CI 0.99-1.07) or admission for septic shock (adjusted HR, 1.04; 95% CI 0.95-1.13). No substantial increased mortality rate was notable beyond the first year for other admission diagnoses. CONCLUSION: Older ICU patients that survive the first year after an ICU admission return to a mortality rate close to that of the general population having similar baseline comorbidity, but variability is seen depending on the ICU admission diagnosis. Trial registration ClinicalTrials.gov ID: NCT06234709, date 02/01/2024.
背景:了解预先存在的合并症如何与危重病相互作用,对于评估 ICU 收治的老年患者的长期生存概率很重要。
材料和方法:在瑞典重症监护登记处登记的≥55 岁的患者首次 ICU 入院后的死亡率与年龄和性别匹配的普通人群进行了比较,以 1 年为标志。使用 Cox 回归比较,调整年龄、性别和基线合并症。
结果:7 年的研究期间包括 140008 名患者,其中 23%为 80 岁或以上。与普通人群相比,存活至第 1 年的患者仍然存在风险增加,但在调整基线合并症后,这种差异大部分减弱(HR,1.03;95%CI,1.02-1.04)。不包括心胸 ICU 入院,风险略有升高(调整 HR,1.15;95%CI,1.13-1.16)。此外,≥75 岁且存活至第 1 年的亚组患者的死亡率恢复到与普通人群相当的水平(HR,0.98;95%CI,0.96-0.99)。按入院诊断分层,急性加重慢性呼吸衰竭(调整 HR,1.47;95%CI,1.36-1.58)的死亡率在第 1 年后仍持续升高,但其他呼吸原因(调整 HR,1.03;95%CI,0.99-1.07)或脓毒症性休克(调整 HR,1.04;95%CI,0.95-1.13)的死亡率无明显升高。对于其他入院诊断,第 1 年后死亡率没有明显升高。
结论:在 ICU 收治后存活第 1 年的老年 ICU 患者的死亡率恢复到接近普通人群的水平,同时存在类似的基线合并症,但根据 ICU 入院诊断,存在一定的变异性。
试验注册:ClinicalTrials.gov ID:NCT06234709,日期 2024 年 2 月 1 日。
Cochrane Database Syst Rev. 2025-8-6
Cochrane Database Syst Rev. 2014-1-30
Pharmacoepidemiol Drug Saf. 2024-4
Ann Intensive Care. 2024-3-30
Anaesthesiol Intensive Ther. 2021